The JSE was stronger on Wednesday alongside European markets as developments in the search for a coronavirus vaccine supported risk appetite.
News that an experimental Covid-19 vaccine trial by US biotech company Moderna has shown immune response in all 45 volunteer patients, lifted market sentiment amid concerns about the rising number of Covid-19 cases.A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
MARKET WRAP: Global risk aversion weakens JSEAs Covid-19 surges globally, and more lockdowns are imposed, safe-haven gold is back in vogue
La source: BDliveSA - 🏆 12. / 63 Lire la suite »
MARKET WRAP: Global economic recovery hopes fuel rand rallyThis week focus shifts to US corporate earnings for the second quarter as investors try to gauge the effect Covid-19 has had on companies there
La source: BDliveSA - 🏆 12. / 63 Lire la suite »
FREE WEBINAR | Connecting the youth market with your brandJoin the Sunday Times Gen Next digital series on Thurs, July 16 at 10am – the speakers will focus on standout campaigns, as voted for by SA’s youth, and aim to help redefine meaningful storytelling and prepare you for the future of marketing.
La source: TimesLIVE - 🏆 28. / 59 Lire la suite »
La source: TheCitizen_News - 🏆 6. / 75 Lire la suite »
Market data — July 13 2020Market data including bonds and fuel prices
La source: BDliveSA - 🏆 12. / 63 Lire la suite »